Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ernexa Therapeutics (ERNA) Shares Issued (2017 - 2025)

Historic Shares Issued for Ernexa Therapeutics (ERNA) over the last 12 years, with Q2 2025 value amounting to $4.9 million.

  • Ernexa Therapeutics' Shares Issued changed N/A to $4.9 million in Q2 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 44809.09%. This contributed to the annual value of $1.1 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Ernexa Therapeutics reported Shares Issued of $4.9 million as of Q2 2025.
  • Over the past 5 years, Ernexa Therapeutics' Shares Issued peaked at $12.0 million during Q1 2022, and registered a low of $4000.0 during Q1 2025.
  • Its 4-year average for Shares Issued is $6.0 million, with a median of $6.3 million in 2022.
  • Examining YoY changes over the last 5 years, Ernexa Therapeutics' Shares Issued showed a top increase of 1449.16% in 2022 and a maximum decrease of 1449.16% in 2022.
  • Quarter analysis of 4 years shows Ernexa Therapeutics' Shares Issued stood at $10.5 million in 2021, then decreased by 26.37% to $7.7 million in 2022, then tumbled by 85.74% to $1.1 million in 2024, then skyrocketed by 347.73% to $4.9 million in 2025.
  • Its last three reported values are $4.9 million in Q2 2025, $4000.0 for Q1 2025, and $1.1 million during Q3 2024.